| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 56 | 2023 | 2119 | 4.120 |
Why?
|
| Tissue and Organ Procurement | 25 | 2018 | 896 | 2.870 |
Why?
|
| Kidney Transplantation | 65 | 2016 | 4251 | 2.660 |
Why?
|
| Tissue Donors | 26 | 2018 | 2240 | 1.610 |
Why?
|
| Organ Transplantation | 15 | 2019 | 1139 | 1.450 |
Why?
|
| Living Donors | 15 | 2011 | 620 | 1.450 |
Why?
|
| Lymphoproliferative Disorders | 13 | 2012 | 523 | 1.210 |
Why?
|
| Health Care Rationing | 5 | 2018 | 437 | 1.150 |
Why?
|
| Graft Rejection | 37 | 2013 | 4397 | 1.060 |
Why?
|
| Patient Selection | 10 | 2019 | 4215 | 0.980 |
Why?
|
| Delayed Graft Function | 2 | 2015 | 48 | 0.880 |
Why?
|
| Social Support | 6 | 2019 | 2118 | 0.870 |
Why?
|
| Liver Neoplasms | 12 | 2016 | 4253 | 0.840 |
Why?
|
| Graft Survival | 22 | 2013 | 3737 | 0.810 |
Why?
|
| Transplantation | 3 | 2018 | 217 | 0.790 |
Why?
|
| Waiting Lists | 15 | 2018 | 692 | 0.760 |
Why?
|
| Immunosuppressive Agents | 18 | 2013 | 4149 | 0.700 |
Why?
|
| Death | 5 | 2011 | 678 | 0.690 |
Why?
|
| Carcinoma, Hepatocellular | 8 | 2016 | 2214 | 0.680 |
Why?
|
| Tissue and Organ Harvesting | 6 | 2011 | 369 | 0.680 |
Why?
|
| Psychology | 1 | 2019 | 356 | 0.610 |
Why?
|
| Antilymphocyte Serum | 11 | 2013 | 492 | 0.600 |
Why?
|
| Resource Allocation | 4 | 2018 | 341 | 0.600 |
Why?
|
| Cyclosporine | 7 | 2009 | 786 | 0.580 |
Why?
|
| Healthcare Disparities | 6 | 2018 | 3158 | 0.570 |
Why?
|
| Tacrolimus | 6 | 2010 | 743 | 0.570 |
Why?
|
| Muromonab-CD3 | 8 | 1998 | 96 | 0.560 |
Why?
|
| Transplants | 1 | 2018 | 209 | 0.550 |
Why?
|
| Postoperative Complications | 21 | 2013 | 15295 | 0.540 |
Why?
|
| Kidney Failure, Chronic | 10 | 2013 | 2538 | 0.530 |
Why?
|
| End Stage Liver Disease | 3 | 2018 | 314 | 0.500 |
Why?
|
| Lung Transplantation | 2 | 2013 | 1153 | 0.500 |
Why?
|
| Carbon Monoxide | 3 | 2012 | 531 | 0.460 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2016 | 264 | 0.460 |
Why?
|
| Reperfusion Injury | 4 | 2015 | 1026 | 0.450 |
Why?
|
| Azygos Vein | 1 | 2012 | 21 | 0.430 |
Why?
|
| Job Satisfaction | 1 | 2016 | 535 | 0.410 |
Why?
|
| Goals | 1 | 2017 | 706 | 0.410 |
Why?
|
| Social Adjustment | 2 | 2011 | 631 | 0.400 |
Why?
|
| Cold Ischemia | 1 | 2011 | 65 | 0.380 |
Why?
|
| Geography | 3 | 2017 | 669 | 0.380 |
Why?
|
| Acute Kidney Injury | 2 | 2015 | 1972 | 0.370 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1796 | 0.360 |
Why?
|
| Physicians, Family | 1 | 2012 | 345 | 0.350 |
Why?
|
| Herpesvirus 4, Human | 11 | 1995 | 1041 | 0.350 |
Why?
|
| Sirolimus | 5 | 2009 | 1564 | 0.350 |
Why?
|
| Workload | 1 | 2016 | 850 | 0.350 |
Why?
|
| Hepatitis B | 2 | 2012 | 695 | 0.350 |
Why?
|
| Hepatectomy | 7 | 2013 | 550 | 0.350 |
Why?
|
| Patient Rights | 1 | 2010 | 126 | 0.350 |
Why?
|
| Abdomen | 1 | 2015 | 1118 | 0.340 |
Why?
|
| Decision Making | 2 | 2020 | 3887 | 0.340 |
Why?
|
| Humans | 167 | 2023 | 744343 | 0.340 |
Why?
|
| Medical Futility | 1 | 2010 | 127 | 0.330 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 440 | 0.330 |
Why?
|
| Creatinine | 3 | 2011 | 1919 | 0.330 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2010 | 178 | 0.330 |
Why?
|
| Ethics Committees | 1 | 2008 | 54 | 0.330 |
Why?
|
| Pancreas Transplantation | 6 | 2009 | 187 | 0.330 |
Why?
|
| Hepatitis B virus | 1 | 2012 | 513 | 0.320 |
Why?
|
| Transplantation Immunology | 5 | 2006 | 546 | 0.320 |
Why?
|
| Critical Pathways | 1 | 2011 | 476 | 0.310 |
Why?
|
| Informed Consent | 2 | 2011 | 995 | 0.300 |
Why?
|
| Psychiatry | 1 | 2019 | 1695 | 0.290 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2023 | 161 | 0.290 |
Why?
|
| Family | 4 | 2019 | 3147 | 0.280 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2008 | 255 | 0.280 |
Why?
|
| Pancreatic Neoplasms | 3 | 2010 | 5256 | 0.280 |
Why?
|
| Medical Errors | 1 | 2014 | 1297 | 0.270 |
Why?
|
| Health Services Accessibility | 3 | 2019 | 5137 | 0.270 |
Why?
|
| Transplantation, Homologous | 16 | 2010 | 4776 | 0.270 |
Why?
|
| Intubation | 1 | 2005 | 141 | 0.260 |
Why?
|
| Liver | 13 | 2017 | 7474 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2010 | 576 | 0.260 |
Why?
|
| Kidney | 9 | 2012 | 7186 | 0.260 |
Why?
|
| Liver Cirrhosis | 5 | 2016 | 1863 | 0.260 |
Why?
|
| Middle Aged | 76 | 2018 | 213383 | 0.250 |
Why?
|
| Physician's Role | 1 | 2012 | 943 | 0.250 |
Why?
|
| Health Status Disparities | 3 | 2018 | 1797 | 0.250 |
Why?
|
| Eligibility Determination | 2 | 2018 | 403 | 0.250 |
Why?
|
| Male | 88 | 2020 | 350118 | 0.240 |
Why?
|
| ABO Blood-Group System | 3 | 2003 | 367 | 0.240 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 2212 | 0.240 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2004 | 32 | 0.230 |
Why?
|
| Biliary Fistula | 1 | 2003 | 36 | 0.230 |
Why?
|
| Reoperation | 6 | 2012 | 4201 | 0.230 |
Why?
|
| Female | 94 | 2019 | 380194 | 0.230 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 2291 | 0.230 |
Why?
|
| Continuity of Patient Care | 2 | 2013 | 1049 | 0.220 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1876 | 0.220 |
Why?
|
| Alcoholism | 3 | 2023 | 1906 | 0.220 |
Why?
|
| Public Policy | 2 | 2017 | 572 | 0.220 |
Why?
|
| Tumor Virus Infections | 4 | 2013 | 452 | 0.210 |
Why?
|
| Adult | 73 | 2018 | 214055 | 0.210 |
Why?
|
| Ultrasonics | 1 | 2003 | 212 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 980 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| United States | 22 | 2019 | 69872 | 0.210 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2001 | 49 | 0.200 |
Why?
|
| Survival Rate | 10 | 2012 | 12788 | 0.200 |
Why?
|
| Histocompatibility Testing | 7 | 2007 | 741 | 0.190 |
Why?
|
| Prognosis | 20 | 2018 | 29063 | 0.190 |
Why?
|
| Ohio | 5 | 2006 | 337 | 0.190 |
Why?
|
| Liver Diseases | 3 | 2011 | 1253 | 0.190 |
Why?
|
| Liver Regeneration | 2 | 2013 | 210 | 0.190 |
Why?
|
| Surgical Instruments | 1 | 2003 | 395 | 0.190 |
Why?
|
| Device Removal | 1 | 2005 | 656 | 0.180 |
Why?
|
| Hepatic Artery | 2 | 2003 | 245 | 0.180 |
Why?
|
| Rimantadine | 1 | 1999 | 9 | 0.170 |
Why?
|
| Referral and Consultation | 2 | 2010 | 3528 | 0.170 |
Why?
|
| Bile Ducts | 1 | 2000 | 284 | 0.170 |
Why?
|
| Skin Transplantation | 3 | 1992 | 1074 | 0.170 |
Why?
|
| Financial Support | 1 | 2019 | 115 | 0.170 |
Why?
|
| Clinical Competence | 1 | 2014 | 4687 | 0.170 |
Why?
|
| Neurilemmoma | 1 | 2004 | 547 | 0.170 |
Why?
|
| Addison Disease | 1 | 1999 | 48 | 0.160 |
Why?
|
| Intestines | 2 | 2005 | 1924 | 0.160 |
Why?
|
| Hospitals, University | 2 | 2009 | 571 | 0.160 |
Why?
|
| Fluconazole | 1 | 1999 | 146 | 0.160 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2000 | 230 | 0.160 |
Why?
|
| Friends | 1 | 2019 | 154 | 0.160 |
Why?
|
| Internet | 2 | 2008 | 3064 | 0.160 |
Why?
|
| Azathioprine | 5 | 2006 | 353 | 0.160 |
Why?
|
| Herpesviridae Infections | 2 | 1995 | 277 | 0.160 |
Why?
|
| Risk Factors | 19 | 2020 | 72290 | 0.160 |
Why?
|
| Ethics, Medical | 1 | 2023 | 792 | 0.160 |
Why?
|
| Transportation | 1 | 2019 | 214 | 0.150 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
| Hepatitis C, Chronic | 2 | 2012 | 1031 | 0.150 |
Why?
|
| Venous Cutdown | 1 | 1996 | 6 | 0.150 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1997 | 134 | 0.150 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 1998 | 194 | 0.150 |
Why?
|
| Registries | 5 | 2007 | 8089 | 0.140 |
Why?
|
| Retrospective Studies | 29 | 2013 | 77449 | 0.140 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2016 | 11 | 0.140 |
Why?
|
| Steroids | 2 | 2013 | 930 | 0.140 |
Why?
|
| Time Factors | 17 | 2013 | 40075 | 0.140 |
Why?
|
| Accidents | 1 | 2017 | 164 | 0.140 |
Why?
|
| Bile Duct Neoplasms | 1 | 2001 | 567 | 0.140 |
Why?
|
| Cholangiocarcinoma | 1 | 2001 | 516 | 0.140 |
Why?
|
| Extracorporeal Circulation | 1 | 1996 | 182 | 0.140 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2016 | 80 | 0.140 |
Why?
|
| Multivariate Analysis | 11 | 2013 | 12245 | 0.140 |
Why?
|
| B-Lymphocytes | 11 | 1991 | 4665 | 0.140 |
Why?
|
| Lymphocele | 2 | 1996 | 16 | 0.140 |
Why?
|
| Follow-Up Studies | 18 | 2018 | 39050 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1996 | 285 | 0.130 |
Why?
|
| Social Class | 2 | 2018 | 1999 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2016 | 5788 | 0.130 |
Why?
|
| Lymphoma | 9 | 1989 | 1877 | 0.130 |
Why?
|
| Databases, Factual | 3 | 2007 | 7729 | 0.130 |
Why?
|
| Adolescent | 32 | 2018 | 85781 | 0.130 |
Why?
|
| Fatigue | 3 | 2011 | 1531 | 0.130 |
Why?
|
| Short Bowel Syndrome | 1 | 1998 | 345 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2009 | 2208 | 0.130 |
Why?
|
| Housing | 1 | 2019 | 664 | 0.120 |
Why?
|
| Neoplasms | 5 | 2007 | 21683 | 0.120 |
Why?
|
| Blood Transfusion | 7 | 2012 | 1301 | 0.120 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1996 | 295 | 0.120 |
Why?
|
| Liver Failure | 2 | 2011 | 241 | 0.120 |
Why?
|
| Quality of Life | 8 | 2011 | 12804 | 0.120 |
Why?
|
| Antifungal Agents | 1 | 1999 | 730 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2018 | 2453 | 0.120 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1999 | 632 | 0.120 |
Why?
|
| Activities of Daily Living | 3 | 2019 | 2418 | 0.120 |
Why?
|
| Lymphocyte Culture Test, Mixed | 6 | 1995 | 517 | 0.110 |
Why?
|
| Hepatitis C | 1 | 2003 | 1591 | 0.110 |
Why?
|
| Survival Analysis | 8 | 2016 | 10252 | 0.110 |
Why?
|
| Vascular Surgical Procedures | 1 | 2022 | 1475 | 0.110 |
Why?
|
| Aged | 32 | 2020 | 163280 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1996 | 549 | 0.110 |
Why?
|
| Treatment Outcome | 15 | 2013 | 63114 | 0.110 |
Why?
|
| Heme Oxygenase-1 | 2 | 2012 | 381 | 0.110 |
Why?
|
| Capillary Permeability | 3 | 1986 | 798 | 0.110 |
Why?
|
| Isoantigens | 2 | 1995 | 567 | 0.110 |
Why?
|
| Opportunistic Infections | 4 | 2010 | 389 | 0.110 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2013 | 66 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2005 | 2788 | 0.110 |
Why?
|
| Hospital Costs | 1 | 1999 | 985 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2015 | 20129 | 0.110 |
Why?
|
| Peritoneal Neoplasms | 1 | 1998 | 665 | 0.110 |
Why?
|
| T-Lymphocytes | 9 | 1995 | 10180 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2005 | 3679 | 0.100 |
Why?
|
| Organ Preservation | 1 | 2015 | 331 | 0.100 |
Why?
|
| BK Virus | 1 | 2013 | 129 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2018 | 1147 | 0.100 |
Why?
|
| Cadaver | 6 | 2009 | 1337 | 0.100 |
Why?
|
| Immunity, Cellular | 4 | 1986 | 1607 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2013 | 23338 | 0.100 |
Why?
|
| Lymphocytes | 4 | 1983 | 2617 | 0.100 |
Why?
|
| Unemployment | 1 | 2013 | 214 | 0.100 |
Why?
|
| Tissue Transplantation | 1 | 2012 | 130 | 0.100 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2012 | 305 | 0.100 |
Why?
|
| Communicable Diseases | 2 | 1997 | 880 | 0.100 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2012 | 215 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1995 | 805 | 0.100 |
Why?
|
| Boston | 4 | 2012 | 9313 | 0.100 |
Why?
|
| Pregnancy Complications | 2 | 2004 | 2861 | 0.100 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 66 | 0.100 |
Why?
|
| Polyomavirus Infections | 1 | 2013 | 197 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 5319 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6364 | 0.090 |
Why?
|
| Mice, SCID | 2 | 1995 | 2716 | 0.090 |
Why?
|
| Cytomegalovirus Infections | 6 | 1996 | 820 | 0.090 |
Why?
|
| Primary Graft Dysfunction | 1 | 2011 | 93 | 0.090 |
Why?
|
| Intraoperative Complications | 3 | 2012 | 1198 | 0.090 |
Why?
|
| Mood Disorders | 3 | 2013 | 1106 | 0.090 |
Why?
|
| Curriculum | 1 | 2023 | 3605 | 0.090 |
Why?
|
| Isoantibodies | 1 | 1993 | 679 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2019 | 2050 | 0.090 |
Why?
|
| Urinalysis | 1 | 2011 | 369 | 0.090 |
Why?
|
| Regression Analysis | 2 | 2018 | 6459 | 0.090 |
Why?
|
| Interleukin-2 | 5 | 2003 | 1904 | 0.090 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1989 | 92 | 0.080 |
Why?
|
| Israel | 1 | 2011 | 796 | 0.080 |
Why?
|
| Social Responsibility | 1 | 2012 | 389 | 0.080 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1988 | 42 | 0.080 |
Why?
|
| Cell Death | 2 | 2013 | 1706 | 0.080 |
Why?
|
| Educational Status | 2 | 2023 | 2540 | 0.080 |
Why?
|
| Spouses | 1 | 2011 | 286 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 4 | 2018 | 7279 | 0.080 |
Why?
|
| Lupus Nephritis | 1 | 1991 | 310 | 0.080 |
Why?
|
| Intestinal Volvulus | 1 | 2009 | 65 | 0.080 |
Why?
|
| Young Adult | 8 | 2018 | 56430 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2007 | 6365 | 0.080 |
Why?
|
| Mandatory Testing | 1 | 2007 | 23 | 0.080 |
Why?
|
| Biopsy | 5 | 2004 | 6756 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 1992 | 1821 | 0.080 |
Why?
|
| Regional Blood Flow | 3 | 1986 | 1525 | 0.080 |
Why?
|
| Altruism | 1 | 2009 | 204 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3508 | 0.080 |
Why?
|
| Colonoscopy | 1 | 2015 | 1367 | 0.080 |
Why?
|
| Directed Tissue Donation | 1 | 2007 | 19 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 1986 | 675 | 0.070 |
Why?
|
| Ventilator Weaning | 1 | 2008 | 148 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 3 | 2009 | 2170 | 0.070 |
Why?
|
| Speech | 1 | 2012 | 540 | 0.070 |
Why?
|
| Antiviral Agents | 2 | 1999 | 2987 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 1254 | 0.070 |
Why?
|
| Lymphocyte Depletion | 1 | 1989 | 608 | 0.070 |
Why?
|
| Child | 21 | 2016 | 77709 | 0.070 |
Why?
|
| Logistic Models | 5 | 2013 | 13408 | 0.070 |
Why?
|
| Lymphokines | 3 | 1986 | 949 | 0.070 |
Why?
|
| Endosonography | 1 | 2010 | 610 | 0.070 |
Why?
|
| Infectious Mononucleosis | 3 | 1988 | 131 | 0.070 |
Why?
|
| Florida | 3 | 2013 | 435 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2022 | 2740 | 0.070 |
Why?
|
| Surgical Wound Infection | 2 | 2012 | 1540 | 0.070 |
Why?
|
| Incidence | 6 | 2008 | 20947 | 0.070 |
Why?
|
| Gallbladder Diseases | 1 | 2006 | 125 | 0.070 |
Why?
|
| Anastomosis, Roux-en-Y | 2 | 2009 | 87 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2013 | 2576 | 0.070 |
Why?
|
| Abdominal Neoplasms | 2 | 1984 | 292 | 0.060 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2003 | 639 | 0.060 |
Why?
|
| Photomicrography | 1 | 2004 | 74 | 0.060 |
Why?
|
| Age Factors | 5 | 2011 | 18370 | 0.060 |
Why?
|
| Cyclosporins | 2 | 1988 | 220 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1992 | 1838 | 0.060 |
Why?
|
| Animals | 23 | 2015 | 168757 | 0.060 |
Why?
|
| Pandemics | 2 | 2023 | 8388 | 0.060 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2005 | 134 | 0.060 |
Why?
|
| Health Policy | 2 | 2013 | 2661 | 0.060 |
Why?
|
| Costs and Cost Analysis | 3 | 1998 | 1681 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1996 | 573 | 0.060 |
Why?
|
| Linear Models | 2 | 2011 | 5952 | 0.060 |
Why?
|
| Hepatic Veins | 1 | 2003 | 112 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3923 | 0.060 |
Why?
|
| Algorithms | 1 | 2004 | 13881 | 0.060 |
Why?
|
| Antifibrinolytic Agents | 1 | 2005 | 254 | 0.060 |
Why?
|
| Mice, Inbred Strains | 4 | 1995 | 1827 | 0.060 |
Why?
|
| Glioblastoma | 1 | 1998 | 3481 | 0.060 |
Why?
|
| Acyclovir | 3 | 1993 | 272 | 0.060 |
Why?
|
| Lymph Nodes | 7 | 1990 | 3474 | 0.050 |
Why?
|
| Recovery of Function | 2 | 2012 | 2925 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2003 | 117 | 0.050 |
Why?
|
| Ligation | 1 | 2003 | 453 | 0.050 |
Why?
|
| HIV Infections | 3 | 2016 | 16718 | 0.050 |
Why?
|
| China | 1 | 2008 | 2248 | 0.050 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2002 | 138 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1990 | 1381 | 0.050 |
Why?
|
| Coronary Thrombosis | 1 | 2005 | 495 | 0.050 |
Why?
|
| Graft vs Host Reaction | 1 | 1982 | 104 | 0.050 |
Why?
|
| Intraoperative Period | 2 | 2007 | 520 | 0.050 |
Why?
|
| Drainage | 2 | 2002 | 1142 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2013 | 2063 | 0.050 |
Why?
|
| Plasma Exchange | 1 | 2003 | 152 | 0.050 |
Why?
|
| Antibodies, Viral | 6 | 1990 | 3176 | 0.050 |
Why?
|
| Hypotension | 1 | 2008 | 884 | 0.050 |
Why?
|
| Health Status | 2 | 2013 | 4034 | 0.050 |
Why?
|
| Thrombosis | 1 | 1996 | 2968 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2013 | 9849 | 0.050 |
Why?
|
| Plasmapheresis | 2 | 1993 | 211 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2278 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 1998 | 8863 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2013 | 6538 | 0.050 |
Why?
|
| Thoracic Neoplasms | 1 | 1983 | 268 | 0.050 |
Why?
|
| Splenectomy | 1 | 2003 | 395 | 0.050 |
Why?
|
| Immune Tolerance | 3 | 2003 | 2258 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2011 | 15540 | 0.050 |
Why?
|
| Guanine | 1 | 1982 | 274 | 0.050 |
Why?
|
| Reimbursement Mechanisms | 1 | 2006 | 670 | 0.050 |
Why?
|
| Jejunostomy | 1 | 2000 | 56 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1855 | 0.050 |
Why?
|
| Lymphocyte Activation | 5 | 1989 | 5524 | 0.050 |
Why?
|
| Swine | 1 | 2010 | 5917 | 0.050 |
Why?
|
| Cholangiography | 1 | 2000 | 189 | 0.050 |
Why?
|
| Prednisone | 2 | 1998 | 1574 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2006 | 1534 | 0.050 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2000 | 97 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 1995 | 9274 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2022 | 720 | 0.040 |
Why?
|
| Safety | 1 | 2004 | 1186 | 0.040 |
Why?
|
| Europe | 1 | 2006 | 3339 | 0.040 |
Why?
|
| Lymphatic Diseases | 1 | 1981 | 324 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2005 | 1050 | 0.040 |
Why?
|
| Mental Health | 1 | 2013 | 3019 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 7913 | 0.040 |
Why?
|
| Immunization, Passive | 3 | 1992 | 623 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2149 | 0.040 |
Why?
|
| Caregivers | 1 | 2011 | 2094 | 0.040 |
Why?
|
| DNA, Satellite | 1 | 1999 | 69 | 0.040 |
Why?
|
| Recurrence | 3 | 2013 | 8340 | 0.040 |
Why?
|
| Clone Cells | 3 | 1989 | 1692 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1991 | 2104 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 1352 | 0.040 |
Why?
|
| Mice, Inbred DBA | 2 | 1995 | 642 | 0.040 |
Why?
|
| Postoperative Care | 3 | 2013 | 1486 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6489 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2012 | 6196 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 3229 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2005 | 1640 | 0.040 |
Why?
|
| Biliary Tract | 1 | 1999 | 134 | 0.040 |
Why?
|
| Morbidity | 2 | 2001 | 1769 | 0.040 |
Why?
|
| Substance-Related Disorders | 2 | 2013 | 4258 | 0.040 |
Why?
|
| Hypoglycemia | 1 | 2005 | 861 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2011 | 10481 | 0.040 |
Why?
|
| Positron-Emission Tomography | 2 | 2012 | 6234 | 0.040 |
Why?
|
| Health Behavior | 1 | 2010 | 2636 | 0.040 |
Why?
|
| Transaminases | 1 | 1998 | 199 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2013 | 4933 | 0.040 |
Why?
|
| Health Promotion | 1 | 2010 | 2205 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2011 | 3022 | 0.040 |
Why?
|
| Spleen | 1 | 1983 | 2362 | 0.040 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1999 | 159 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2004 | 1063 | 0.040 |
Why?
|
| Complement System Proteins | 2 | 1991 | 795 | 0.040 |
Why?
|
| Mice | 15 | 2013 | 81183 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2005 | 812 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1462 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2004 | 1236 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 1999 | 802 | 0.040 |
Why?
|
| Colorectal Neoplasms | 2 | 2007 | 6773 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 6 | 2013 | 21827 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 4262 | 0.030 |
Why?
|
| Rabbits | 2 | 2013 | 4894 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 1996 | 1799 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1995 | 2942 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1996 | 554 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4245 | 0.030 |
Why?
|
| Pregnancy | 4 | 2008 | 29144 | 0.030 |
Why?
|
| Fatty Liver | 2 | 1993 | 727 | 0.030 |
Why?
|
| Radiography | 4 | 2005 | 7023 | 0.030 |
Why?
|
| Pilot Projects | 2 | 1999 | 8324 | 0.030 |
Why?
|
| Reproducibility of Results | 5 | 2011 | 19905 | 0.030 |
Why?
|
| Cell Communication | 1 | 1982 | 1621 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 1998 | 936 | 0.030 |
Why?
|
| Celiac Disease | 1 | 2002 | 785 | 0.030 |
Why?
|
| Infant | 8 | 2009 | 35136 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9438 | 0.030 |
Why?
|
| Child, Preschool | 9 | 2009 | 41006 | 0.030 |
Why?
|
| Pheochromocytoma | 1 | 1996 | 337 | 0.030 |
Why?
|
| H-2 Antigens | 2 | 1992 | 366 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 1998 | 650 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2005 | 12959 | 0.030 |
Why?
|
| Vascular Patency | 1 | 1996 | 886 | 0.030 |
Why?
|
| Viral Load | 2 | 2012 | 3299 | 0.030 |
Why?
|
| Pediatrics | 1 | 2008 | 3475 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2005 | 2151 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1995 | 565 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1994 | 349 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2001 | 3479 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 1995 | 5974 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 5987 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 2376 | 0.030 |
Why?
|
| Blood Group Incompatibility | 1 | 1993 | 146 | 0.030 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 7785 | 0.030 |
Why?
|
| Virus Replication | 2 | 1995 | 2534 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2009 | 3336 | 0.030 |
Why?
|
| Pancreatectomy | 2 | 2009 | 804 | 0.030 |
Why?
|
| Hyperplasia | 2 | 2005 | 1185 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2009 | 25625 | 0.030 |
Why?
|
| Intestine, Small | 1 | 1998 | 1241 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 9959 | 0.030 |
Why?
|
| Prevalence | 1 | 2009 | 15226 | 0.030 |
Why?
|
| Histocompatibility | 1 | 1993 | 330 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2016 | 40561 | 0.030 |
Why?
|
| Necrosis | 1 | 1996 | 1643 | 0.020 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1998 | 934 | 0.020 |
Why?
|
| Hepacivirus | 1 | 1999 | 1379 | 0.020 |
Why?
|
| RNA, Viral | 2 | 1999 | 2902 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 14722 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 1996 | 1641 | 0.020 |
Why?
|
| Anastomotic Leak | 1 | 2012 | 162 | 0.020 |
Why?
|
| Insulin | 1 | 2005 | 6580 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 1992 | 528 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 1996 | 2886 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 592 | 0.020 |
Why?
|
| Outpatients | 1 | 1998 | 1486 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2007 | 9239 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 1991 | 1095 | 0.020 |
Why?
|
| Genes, Viral | 2 | 1981 | 718 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1995 | 1475 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 1991 | 326 | 0.020 |
Why?
|
| Obesity | 2 | 2010 | 12745 | 0.020 |
Why?
|
| Predictive Value of Tests | 4 | 2012 | 15076 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 113 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1590 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 270 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2016 | 2618 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1998 | 2382 | 0.020 |
Why?
|
| Pancreas | 2 | 2005 | 1686 | 0.020 |
Why?
|
| Ricin | 1 | 1989 | 72 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1994 | 1402 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1993 | 652 | 0.020 |
Why?
|
| Attitude to Death | 1 | 2011 | 382 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 1991 | 372 | 0.020 |
Why?
|
| Hepatic Encephalopathy | 1 | 1990 | 139 | 0.020 |
Why?
|
| Affective Symptoms | 1 | 2011 | 407 | 0.020 |
Why?
|
| Capsid | 2 | 1981 | 436 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2505 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 1366 | 0.020 |
Why?
|
| Immunotoxins | 1 | 1989 | 179 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1994 | 711 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2010 | 319 | 0.020 |
Why?
|
| Thymectomy | 1 | 1989 | 191 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 1991 | 1369 | 0.020 |
Why?
|
| Equipment Design | 1 | 1996 | 3582 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 1581 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 804 | 0.020 |
Why?
|
| Length of Stay | 1 | 2001 | 6309 | 0.020 |
Why?
|
| Mycophenolic Acid | 1 | 2009 | 343 | 0.020 |
Why?
|
| Culture Media | 2 | 1986 | 908 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1530 | 0.020 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2010 | 657 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 12354 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 517 | 0.020 |
Why?
|
| Burkitt Lymphoma | 1 | 1989 | 327 | 0.020 |
Why?
|
| Acute Disease | 3 | 1993 | 7149 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1985 | 1375 | 0.020 |
Why?
|
| Proteinuria | 1 | 2009 | 658 | 0.020 |
Why?
|
| Bradykinin | 1 | 1986 | 214 | 0.020 |
Why?
|
| Inpatients | 1 | 1998 | 2518 | 0.020 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2012 | 570 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1988 | 488 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 2011 | 643 | 0.020 |
Why?
|
| Erythropoietin | 1 | 1991 | 726 | 0.020 |
Why?
|
| Dumping Syndrome | 1 | 2005 | 18 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1996 | 4199 | 0.020 |
Why?
|
| Prospective Studies | 5 | 2012 | 53288 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1994 | 1401 | 0.020 |
Why?
|
| Brain Death | 1 | 2009 | 348 | 0.020 |
Why?
|
| Diazoxide | 1 | 2005 | 57 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.020 |
Why?
|
| Albuminuria | 1 | 2009 | 682 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 10943 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1985 | 154 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 1990 | 732 | 0.020 |
Why?
|
| Cross-Sectional Studies | 4 | 2010 | 25043 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 3 | 1983 | 6386 | 0.020 |
Why?
|
| Octreotide | 1 | 2005 | 145 | 0.020 |
Why?
|
| Histamine | 1 | 1986 | 507 | 0.020 |
Why?
|
| JC Virus | 1 | 2005 | 85 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 35421 | 0.020 |
Why?
|
| Collagen | 1 | 2013 | 2689 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2171 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2559 | 0.020 |
Why?
|
| Diet Therapy | 1 | 2005 | 154 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 1150 | 0.020 |
Why?
|
| Ataxia Telangiectasia | 1 | 1985 | 112 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2003 | 5686 | 0.010 |
Why?
|
| Polysomnography | 1 | 2010 | 1776 | 0.010 |
Why?
|
| Indium | 1 | 1983 | 46 | 0.010 |
Why?
|
| Urethane | 1 | 1983 | 40 | 0.010 |
Why?
|
| Inflammation | 2 | 1984 | 10638 | 0.010 |
Why?
|
| Duodenum | 1 | 1987 | 483 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1989 | 1842 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2007 | 783 | 0.010 |
Why?
|
| Immunization | 2 | 1988 | 1256 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2018 | 5102 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1986 | 1263 | 0.010 |
Why?
|
| Skin | 2 | 1989 | 4364 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2967 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2011 | 2052 | 0.010 |
Why?
|
| Serotonin | 1 | 1986 | 1017 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1997 | 4445 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 2645 | 0.010 |
Why?
|
| Immunoglobulin M | 2 | 1990 | 1537 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1983 | 499 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1989 | 19229 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 57776 | 0.010 |
Why?
|
| Heart Transplantation | 3 | 1994 | 3110 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4851 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2902 | 0.010 |
Why?
|
| Reference Values | 1 | 1989 | 4982 | 0.010 |
Why?
|
| Preoperative Care | 2 | 1988 | 2250 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1981 | 218 | 0.010 |
Why?
|
| Antigens, Ly | 1 | 1982 | 291 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 3966 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 986 | 0.010 |
Why?
|
| Massachusetts | 1 | 2013 | 8663 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2012 | 2958 | 0.010 |
Why?
|
| Body Weight | 1 | 2011 | 4669 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1985 | 1267 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5720 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 1364 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8428 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2005 | 847 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1992 | 4386 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1988 | 3206 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 13102 | 0.010 |
Why?
|
| Bronchitis | 1 | 1980 | 201 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 3396 | 0.010 |
Why?
|
| Pharynx | 1 | 1981 | 413 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 987 | 0.010 |
Why?
|
| Immunity | 1 | 1985 | 1012 | 0.010 |
Why?
|
| Sepsis | 1 | 2012 | 2593 | 0.010 |
Why?
|
| Brain | 1 | 2005 | 26385 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 1983 | 1285 | 0.010 |
Why?
|
| Cell Count | 1 | 1982 | 1856 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1981 | 547 | 0.010 |
Why?
|
| Health Surveys | 1 | 2007 | 4037 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1985 | 2765 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1981 | 1035 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 1999 | 644 | 0.010 |
Why?
|
| Pain | 1 | 2011 | 4986 | 0.010 |
Why?
|
| Chlamydia Infections | 1 | 1980 | 365 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2005 | 2109 | 0.010 |
Why?
|
| Cytokines | 1 | 2011 | 7322 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2007 | 2531 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14557 | 0.010 |
Why?
|
| Lymphatic System | 1 | 1977 | 253 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1980 | 530 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1982 | 1951 | 0.010 |
Why?
|
| Ganciclovir | 1 | 1996 | 258 | 0.010 |
Why?
|
| Genotype | 1 | 1990 | 12951 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 6256 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 1990 | 4560 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 6895 | 0.010 |
Why?
|
| Kinetics | 1 | 1982 | 6473 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1994 | 370 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 21746 | 0.010 |
Why?
|
| Cell Movement | 2 | 1983 | 5217 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2010 | 12720 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2006 | 3114 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 8554 | 0.010 |
Why?
|
| DNA | 1 | 1985 | 7301 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.010 |
Why?
|
| Risk | 1 | 1983 | 9687 | 0.010 |
Why?
|
| Physicians | 1 | 2009 | 4567 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1994 | 470 | 0.010 |
Why?
|
| Colon | 1 | 1999 | 1772 | 0.010 |
Why?
|
| Ascites | 1 | 1991 | 344 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1991 | 6622 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1993 | 8642 | 0.010 |
Why?
|
| Plateletpheresis | 1 | 1988 | 47 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1987 | 5751 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1996 | 1738 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2011 | 23403 | 0.000 |
Why?
|
| Pneumonia | 1 | 1980 | 2133 | 0.000 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1990 | 571 | 0.000 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1987 | 107 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1993 | 3913 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1991 | 1381 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 11366 | 0.000 |
Why?
|
| Plasma | 1 | 1988 | 575 | 0.000 |
Why?
|
| Leukocyte Transfusion | 1 | 1984 | 60 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1988 | 2008 | 0.000 |
Why?
|
| Erythrocyte Transfusion | 1 | 1988 | 565 | 0.000 |
Why?
|
| Porifera | 1 | 1983 | 33 | 0.000 |
Why?
|
| Caseins | 1 | 1983 | 104 | 0.000 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1984 | 307 | 0.000 |
Why?
|
| Serum Albumin, Bovine | 1 | 1983 | 324 | 0.000 |
Why?
|
| Desensitization, Immunologic | 1 | 1987 | 483 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15165 | 0.000 |
Why?
|
| Sex Factors | 1 | 1994 | 10397 | 0.000 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1984 | 340 | 0.000 |
Why?
|
| Karyotyping | 1 | 1981 | 1243 | 0.000 |
Why?
|
| Chlamydia trachomatis | 1 | 1980 | 246 | 0.000 |
Why?
|
| Lymph | 1 | 1977 | 80 | 0.000 |
Why?
|
| Cell Separation | 1 | 1983 | 1751 | 0.000 |
Why?
|
| Cattle | 1 | 1983 | 3922 | 0.000 |
Why?
|
| Thoracic Duct | 1 | 1977 | 63 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1981 | 1539 | 0.000 |
Why?
|
| Lymphography | 1 | 1977 | 201 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1984 | 3616 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1981 | 1813 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1981 | 2225 | 0.000 |
Why?
|
| Specimen Handling | 1 | 1977 | 694 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1984 | 2541 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1981 | 3748 | 0.000 |
Why?
|
| Catheterization | 1 | 1977 | 1470 | 0.000 |
Why?
|
| Macrophages | 1 | 1984 | 5655 | 0.000 |
Why?
|
| Models, Biological | 1 | 1984 | 9583 | 0.000 |
Why?
|
| Phenotype | 1 | 1983 | 16365 | 0.000 |
Why?
|
| Lung | 1 | 1980 | 9856 | 0.000 |
Why?
|